Overview

CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques

Status:
Active, not recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the safety and efficacy of CCH for the treatment of edematous fibrosclerotic panniculopathy (cellulite) in participants with moderate to severe dermal laxity in buttocks and thighs with comparison between two (2) different CCH injection techniques.
Phase:
Phase 2
Details
Lead Sponsor:
Endo Pharmaceuticals